MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a

Sormani, MP; Freedman, MS; Aldridge, J; Marhardt, K; Kappos, L; De Stefano, N

Sormani, MP (corresponding author), Dept Hlth Sci DISSAL, Via Pastore 1, I-16132 Genoa, Italy.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021; 49 ():

Abstract

Background: Subcutaneous (sc) interferon (IFN) ?-1a reduces relapse rates and delays disability progression in patients with MS. We examined the assoc......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索